Spots Global Cancer Trial Database for leuprorelin
Every month we try and update this database with for leuprorelin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448 | NCT01132404 | Prostate Cancer Prostatic Neopl... | Leuprorelin TAK-448 | 40 Years - 72 Years | Millennium Pharmaceuticals, Inc. | |
| A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease | NCT05478083 | Polycystic Live... Autosomal Domin... | Leuprorelin | 18 Years - 45 Years | University Medical Center Groningen | |
| A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia | NCT05440383 | Uterine Fibroid... | KLH-2109 Leuprorelin | 20 Years - | Kissei Pharmaceutical Co., Ltd. | |
| Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448 | NCT01132404 | Prostate Cancer Prostatic Neopl... | Leuprorelin TAK-448 | 40 Years - 72 Years | Millennium Pharmaceuticals, Inc. | |
| Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland | NCT05701007 | Metastatic Cast... Metastatic Cast... | abiraterone enzalutamide docetaxel apalutamide cabazitaxel Radium-223 Lutetium-177 degarelix goserelin leuprorelin triptorelin | 18 Years - | Pfizer | |
| Exploratory Study of Molecular Profile-Associated Evidence Guided Precision Therapy for Salivary Gland Cancer（MAPS） | NCT05087706 | Salivary Gland ... | Pyrotinib Bicalutamide Leuprorelin | 18 Years - | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | |
| A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate Cancer | NCT02083185 | Prostate Cancer | Relugolix Leuprorelin | 18 Years - | Takeda | |
| Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer | NCT01989780 | Metastatic Brea... | Paclitaxel Bevacizumab Letrozole Anastrozole Exemestane Fulvestrant Goserelin leuprorelin | 20 Years - 75 Years | Japan Breast Cancer Research Group | |
| A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids | NCT02655237 | Uterine Fibroid... | Relugolix Relugolix Place... Leuprorelin Leuprorelin Pla... | 20 Years - | Takeda | |
| A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids | NCT02655237 | Uterine Fibroid... | Relugolix Relugolix Place... Leuprorelin Leuprorelin Pla... | 20 Years - | Takeda | |
| Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,c | NCT00817739 | Prostatic Neopl... | Leuprorelin Flutamide | 18 Years - | Takeda | |
| Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer | NCT01989780 | Metastatic Brea... | Paclitaxel Bevacizumab Letrozole Anastrozole Exemestane Fulvestrant Goserelin leuprorelin | 20 Years - 75 Years | Japan Breast Cancer Research Group | |
| Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma | NCT01011751 | Adenocarcinoma,... | Cyproterone ace... Medroxyprogeste... Venlafaxine Leuprorelin Flutamide Placebo | 18 Years - | Takeda | |
| Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448 | NCT01132404 | Prostate Cancer Prostatic Neopl... | Leuprorelin TAK-448 | 40 Years - 72 Years | Millennium Pharmaceuticals, Inc. | |
| Exploratory Study of Molecular Profile-Associated Evidence Guided Precision Therapy for Salivary Gland Cancer（MAPS） | NCT05087706 | Salivary Gland ... | Pyrotinib Bicalutamide Leuprorelin | 18 Years - | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | |
| PGL4001 Versus GnRH-agonist in Uterine Myomas | NCT00740831 | Uterine Myomas | PGL4001 leuprorelin | 18 Years - 50 Years | PregLem SA | |
| A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate Cancer | NCT02083185 | Prostate Cancer | Relugolix Leuprorelin | 18 Years - | Takeda | |
| Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,c | NCT00817739 | Prostatic Neopl... | Leuprorelin Flutamide | 18 Years - | Takeda | |
| Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448 | NCT01132404 | Prostate Cancer Prostatic Neopl... | Leuprorelin TAK-448 | 40 Years - 72 Years | Millennium Pharmaceuticals, Inc. | |
| A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia | NCT05440383 | Uterine Fibroid... | KLH-2109 Leuprorelin | 20 Years - | Kissei Pharmaceutical Co., Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
